Product Information
NEOMYC-POLYM-DEXAMETH EYE DROP is a generic product labeled by Sandoz Inc., priced at $1.7823 per ML under NDC 61314063006. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 22, 1984. Its Orange Book therapeutic-equivalence code is AT.
Strength
1; 3.5; 10000 mg/mL; mg/mL; [USP'U]/mL
Manufacturer
Sandoz Inc.NDC
61314063006
Classification
Generic
Dosage Form
SUSPENSION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA062341FDA Approved
5/22/1984
TE Code
AT
On Market Since
2/21/1996
Pharmacological Classes
Price Statistics
The NADAC for NEOMYC-POLYM-DEXAMETH EYE DROP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 44.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7823 per ML |
|---|---|
| All-time high | $3.4623 (Apr 16, 2014) |
| All-time low | $1.6081 (Jul 22, 2026) |
| 52-week high | $1.9978 |
| 52-week low | $1.6081 |
| Median price | $2.6710 |
| Average price | $2.6253 |
| Largest weekly change | +23.5% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
neomycin sulfate, polymyxin b sulfate and dexamethasone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEOMYC-POLYM-DEXAMETH EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for NEOMYC-POLYM-DEXAMETH EYE DROP, manufactured by Sandoz Inc., is $1.7823 per ML (NDC 61314063006), effective Sep 30, 2026.
How has the price of NEOMYC-POLYM-DEXAMETH EYE DROP changed over time?
Over the history we have for it, the NADAC for NEOMYC-POLYM-DEXAMETH EYE DROP has declined 44.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEOMYC-POLYM-DEXAMETH EYE DROP?
Since Nov 28, 2013, the NADAC for NEOMYC-POLYM-DEXAMETH EYE DROP has ranged from a low of $1.6081 (Jul 22, 2026) to a high of $3.4623 (Apr 16, 2014), with a median of $2.6710 per ML.
Are there cheaper alternatives to NEOMYC-POLYM-DEXAMETH EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NEOMYC-POLYM-DEXAMETH EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures NEOMYC-POLYM-DEXAMETH EYE DROP?
NEOMYC-POLYM-DEXAMETH EYE DROP (NDC 61314063006) is labeled by Sandoz Inc., and CMS classifies it as a generic product.